A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of ASM-024 Administered by Dry Powder Inhalation to Healthy Subjects and Subjects With Stable Moderate Asthma

Trial Profile

A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of ASM-024 Administered by Dry Powder Inhalation to Healthy Subjects and Subjects With Stable Moderate Asthma

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 16 Feb 2015

At a glance

  • Drugs ASM 024 (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Asmacure
  • Most Recent Events

    • 08 Feb 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
    • 02 Jun 2014 Planned End Date changed from 1 May 2014 to 1 Apr 2015 as reported by ClinicalTrials.gov.
    • 02 Apr 2014 Planned End Date changed from 1 Mar 2014 to 1 May 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top